Signature biomarker states and mortality among hospitalized SARS-CoV-2-infected patients
J Nephrol
.
2022 Apr;35(3):765-767.
doi: 10.1007/s40620-021-01239-z.
Epub 2022 Jan 6.
Authors
Caitlin Selvaggi
1
,
Linda J Harrison
1
2
,
Eunyoung Kim
3
,
Muredach P Reilly
3
4
,
Andrea S Foulkes
5
6
7
Affiliations
1
Biostatistics Center, Massachusetts General Hospital, 50 Staniford Street, Boston, MA, 02114, USA.
2
Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
3
Division of Cardiology, Columbia University, New York, NY, USA.
4
Irving Institute for Clinical and Translational Research, Columbia University, New York, USA.
5
Biostatistics Center, Massachusetts General Hospital, 50 Staniford Street, Boston, MA, 02114, USA. afoulkes@mgh.harvard.edu.
6
Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA. afoulkes@mgh.harvard.edu.
7
Department of Medicine, Harvard Medical School, Boston, USA. afoulkes@mgh.harvard.edu.
PMID:
34989977
PMCID:
PMC8733911
DOI:
10.1007/s40620-021-01239-z
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
MeSH terms
Biomarkers
COVID-19*
Humans
SARS-CoV-2*
Substances
Biomarkers
Grants and funding
K24 HL107643/HL/NHLBI NIH HHS/United States
R01 GM127862/GM/NIGMS NIH HHS/United States